These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
383 related items for PubMed ID: 25761921
1. Evaluation of hot-melt extrusion and injection molding for continuous manufacturing of immediate-release tablets. Melocchi A, Loreti G, Del Curto MD, Maroni A, Gazzaniga A, Zema L. J Pharm Sci; 2015 Jun; 104(6):1971-1980. PubMed ID: 25761921 [Abstract] [Full Text] [Related]
8. Gastroresistant capsular device prepared by injection molding. Zema L, Loreti G, Melocchi A, Maroni A, Palugan L, Gazzaniga A. Int J Pharm; 2013 Jan 20; 440(2):264-72. PubMed ID: 22683648 [Abstract] [Full Text] [Related]
9. Klucel™ EF and ELF polymers for immediate-release oral dosage forms prepared by melt extrusion technology. Mohammed NN, Majumdar S, Singh A, Deng W, Murthy NS, Pinto E, Tewari D, Durig T, Repka MA. AAPS PharmSciTech; 2012 Dec 20; 13(4):1158-69. PubMed ID: 22961411 [Abstract] [Full Text] [Related]
10. Development of immediate release (IR) 3D-printed oral dosage forms with focus on industrial relevance. Fanous M, Gold S, Hirsch S, Ogorka J, Imanidis G. Eur J Pharm Sci; 2020 Dec 01; 155():105558. PubMed ID: 32946957 [Abstract] [Full Text] [Related]
11. Thermoplastic polyurethanes for the manufacturing of highly dosed oral sustained release matrices via hot melt extrusion and injection molding. Claeys B, Vervaeck A, Hillewaere XK, Possemiers S, Hansen L, De Beer T, Remon JP, Vervaet C. Eur J Pharm Biopharm; 2015 Feb 01; 90():44-52. PubMed ID: 25448075 [Abstract] [Full Text] [Related]
12. Integrated hot-melt extrusion - injection molding continuous tablet manufacturing platform: Effects of critical process parameters and formulation attributes on product robustness and dimensional stability. Desai PM, Hogan RC, Brancazio D, Puri V, Jensen KD, Chun JH, Myerson AS, Trout BL. Int J Pharm; 2017 Oct 05; 531(1):332-342. PubMed ID: 28844899 [Abstract] [Full Text] [Related]
13. Formulation and development of pH-independent/dependent sustained release matrix tablets of ondansetron HCl by a continuous twin-screw melt granulation process. Patil H, Tiwari RV, Upadhye SB, Vladyka RS, Repka MA. Int J Pharm; 2015 Dec 30; 496(1):33-41. PubMed ID: 25863118 [Abstract] [Full Text] [Related]
14. Influence of pressurized carbon dioxide on ketoprofen-incorporated hot-melt extruded low molecular weight hydroxypropylcellulose. A Ashour E, Kulkarni V, Almutairy B, Park JB, Shah SP, Majumdar S, Lian Z, Pinto E, Bi V, Durig T, Martin ST, Repka MA. Drug Dev Ind Pharm; 2016 Jan 30; 42(1):123-130. PubMed ID: 25997363 [Abstract] [Full Text] [Related]
15. Formulating Amorphous Solid Dispersions: Impact of Inorganic Salts on Drug Release from Tablets Containing Itraconazole-HPMC Extrudate. Takano R, Maurer R, Jacob L, Stowasser F, Stillhart C, Page S. Mol Pharm; 2020 Aug 03; 17(8):2768-2778. PubMed ID: 31794228 [Abstract] [Full Text] [Related]
16. The Influence of the Polymer Type on the Quality of Newly Developed Oral Immediate-Release Tablets Containing Amiodarone Solid Dispersions Obtained by Hot-Melt Extrusion. Fița AC, Secăreanu AA, Musuc AM, Ozon EA, Sarbu I, Atkinson I, Rusu A, Mati E, Anuta V, Pop AL. Molecules; 2022 Oct 05; 27(19):. PubMed ID: 36235137 [Abstract] [Full Text] [Related]
17. A New Extrudable Form of Hypromellose: AFFINISOL™ HPMC HME. Huang S, O'Donnell KP, Keen JM, Rickard MA, McGinity JW, Williams RO. AAPS PharmSciTech; 2016 Feb 05; 17(1):106-19. PubMed ID: 26335416 [Abstract] [Full Text] [Related]
18. Co-extrusion as manufacturing technique for fixed-dose combination mini-matrices. Dierickx L, Saerens L, Almeida A, De Beer T, Remon JP, Vervaet C. Eur J Pharm Biopharm; 2012 Aug 05; 81(3):683-9. PubMed ID: 22504402 [Abstract] [Full Text] [Related]
19. Stabilization of fenofibrate in low molecular weight hydroxypropylcellulose matrices produced by hot-melt extrusion. Deng W, Majumdar S, Singh A, Shah S, Mohammed NN, Jo S, Pinto E, Tewari D, Durig T, Repka MA. Drug Dev Ind Pharm; 2013 Feb 05; 39(2):290-8. PubMed ID: 22524504 [Abstract] [Full Text] [Related]
20. Designing robust immediate release tablet formulations avoiding food effects for BCS class 3 drugs. Zaheer K, Langguth P. Eur J Pharm Biopharm; 2019 Jun 05; 139():177-185. PubMed ID: 30902732 [Abstract] [Full Text] [Related] Page: [Next] [New Search]